Carta Healthcare Closes Series A Funding to Accelerate Growth

San Francisco, CA – [April 7, 2021] — Carta Healthcare, a provider of AI-powered clinical data abstraction technology and services, is pleased to announce a recent $17.3M Series A investment led by Storm Ventures. AI Digital Innovation Fund (affiliated with Mass General Brigham), CU Health Innovation Fund (affiliated with University of Colorado Anschutz Medical Campus), Asset Management Ventures, Maverick Ventures, Healthy Ventures, Waterline Ventures, Seven Peaks Ventures, Katalyst Ventures, and Atypical Ventures also participated in the round.

“Using data to improve patient care has always been the mission for our team and the reason we launched this venture in 2017,” said Matt Hollingsworth, CEO and co-founder of Carta Healthcare. “Our commitment to this mission brought together a motivated and uniquely qualified team that turned our vision into a reality. The effectiveness of the solutions we built has led to our significant growth over the past year, and we plan to use this new investment to bring our solution to new partners. This investment further validates the need to have trustworthy, actionable data to drive improvements in healthcare and will allow us to deliver on our ultimate promise — to make people healthier.”

Storm Ventures is an early-stage, B2B-focused venture firm specializing in building enterprise leaders. “The leaders at Carta have decades of combined experience understanding the nuances of healthcare delivery,” said Arun Penmetsa, partner at Storm Ventures. “As a result, they have built an incredible platform to unlock the value of health data. We’re thrilled to join them in this journey.”

Maverick Ventures is a global investment firm for early-stage companies. Maverick’s Ambar Bhattacharyya adds, “Having worked with Carta over the past two years, we are excited to continue supporting the team as it reaches its next stage of growth. The company is a great example of how passion and innovation can come together and solve problems faced by the healthcare industry.”

AMV is an early-stage venture capital firm specializing in digital health and an existing investor in Carta. Skip Fleshman, partner at AMV, adds, “We have a long history of identifying emerging trends and opportunities in the digital health space, and we believe the team at Carta offers a truly differentiated approach to removing the existing friction in data collection and normalization. We look forward to helping them build on their current success.”

About Carta Healthcare
Founded in 2017, Carta Healthcare’s mission is to improve patient care by harnessing the value of clinical data. Through its combination of industry-leading, AI-driven technology and multidisciplinary team of experts, Carta Healthcare has transformed the traditional clinical data abstraction process. The company’s agile, innovative approach to expertise+technology allows healthcare organizations to collect, analyze, and act on their clinical and operational data in a fraction of the time. The result is high-quality, accurate, trustworthy datasets for use across a healthcare organization’s initiatives to operate more efficiently, optimize care delivery, improve patient outcomes, and allow clinicians to practice at the top of their license. For more information, visit www.carta.healthcare or contact us at hello@carta.healthcare.

 

Media Contact:

Carta Healthcare
Kristi Lee-John
919.270.8054
klee@crossroadsb2b.com